## CNP: CenterPoint Energy, Inc (Holdin - XLU: Utilities

### Executive Summary

No thesis match: MRS_20 -0.3% below STRENGTH zone (4.0-10.0%); PEG 2.27 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($37.11)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Precision Trading with Centerpoint Energy Inc (holding Co) (CNP) Risk Zones**
- Source: Stock Traders Daily | 20251217T233000 | Neutral | Relevance: 100%
- This article provides a detailed analysis of Centerpoint Energy Inc (CNP) using AI-generated signals and trading strategies. It highlights divergent sentiment, elevated downside risk, and offers specific long, breakout, and short strategies with entry zones, targets, and stop losses. The analysis also includes a multi-timeframe signal breakdown for near-term, mid-term, and long-term horizons.

**2. UBS Adjusts CenterPoint Energy Price Target to $43 From $45, Maintains Buy Rating**
- Source: marketscreener.com | 20251217T151642 | Somewhat-Bullish | Relevance: 100%
- UBS has adjusted its price target for CenterPoint Energy (NYSE:CNP) from $45 to $43, while reiterating a "Buy" rating on the stock. This adjustment reflects a recent analyst move, alongside other financial news concerning the energy company, such as Scotiabank's price target adjustment and CenterPoint Energy's dividend increase. The article provides an overview of recent analyst recommendations and company news for CenterPoint Energy.

**3. Scotiabank Adjusts Price Target on CenterPoint Energy to $49 From $45, Maintains Sector Outperform Rating**
- Source: marketscreener.com | 20251216T151458 | Bullish | Relevance: 100%
- Scotiabank has increased its price target for CenterPoint Energy (CNP) from $45 to $49, while maintaining a Sector Outperform rating. This adjustment reflects a positive outlook on the company, reiterated by the continued outperform rating. The article also provides a glimpse into recent news and analyst activities related to CenterPoint Energy.

**4. CenterPoint Energy (CNP): Reassessing Valuation After Analyst Upgrade, AI Partnership Buzz and Solid Dividend Performance**
- Source: Sahm | 20251216T020928 | Somewhat-Bullish | Relevance: 100%
- CenterPoint Energy (CNP) is gaining investor attention due to an analyst upgrade, strong quarterly results, a steady dividend, and its role in Palantir Chain Reaction, leading to a 20% year-to-date share price return. While analysts see upside with a fair value near $42.38, its P/E ratio of 23.8x suggests it's richer than peers, indicating less of an obvious bargain despite the growth potential from AI infrastructure buzz. Investors are encouraged to research further using tools like the Simply Wall St Screener for other undervalued stocks.

**5. 5 Stocks Worth Watching on Their Recent Dividend Hikes**
- Source: TradingView â€” Track All Markets | 20251217T130809 | Bullish | Relevance: 91%
- Amidst market volatility and concerns over economic growth, this article highlights five dividend-paying stocks that have recently hiked their dividends, indicating strong financial health. Investors seeking to diversify their portfolios and counter market upheavals are advised to consider companies like Pentair, nVent Electric, CenterPoint Energy, Marriott Vacations Worldwide, and PG&E, which consistently reward shareholders. The article provides details on each company's dividend history, yield, and payout ratio.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | UBS | $43 | $45 | -4% |
| 2025-12-12 | Keybanc | $41 | $0 | 0% |
| 2025-12-11 | JP Morgan | $41 | $43 | -5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | UBS | main | Buy |
| 2025-12-12 | Keybanc | up | Overweight |
| 2025-12-11 | JP Morgan | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 1 ($0.24M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 59.3% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Capital Internationa: 13.4% (+1.0%)
- Vanguard Group Inc: 12.5% (+0.4%)
- Blackrock Inc.: 8.5% (+2.6%)
- T. Rowe Price Invest: 7.9% (+7.6%)
- State Street Corpora: 5.2% (+2.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.27 elevated, pricing in significant growth expectations. Forward P/E 20.0x stretched relative to 8% growth. Analyst sentiment negative (2 target cuts vs 0 raises). Institutional flow bearish (4 selling vs 6 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $25.0B |
| Beta | 0.56 |
| 52W Range | $30.59 - $40.50 |
| Short Interest | 7.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.27 |
| Forward P/E | 20.0 |
| Current P/E | 21.7 |
| YoY Growth | 8.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -3.2% to -0.3% (+2.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 4.3pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.3%) - potential reversal signal. Long-term uptrend intact (above SMA200 at 1.01x) but short-term weakness (below SMA20). RSI neutral at 45. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.34% (CS: 37) | Neutral |
| RSI_14 | 44.6 | Neutral |
| MACD Histogram | -0.02 | Bearish |
| vs SMA20 | 0.990x | Below |
| vs SMA50 | 0.977x | Below |
| vs SMA200 | 1.014x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $38.23
- **Stop Loss:** $37.11 (2.9% risk)
- **Target:** $39.35 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 848
- **Position Value:** $32,419.04
- **Portfolio %:** 32.42%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-19 (Est: $0.48)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.44 | $0.50 | +12.6% |
| 2025Q2 | $0.30 | $0.29 | -4.6% |
| 2025Q1 | $0.53 | $0.53 | -0.8% |
| 2024Q4 | $0.40 | $0.40 | -0.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*